World Journal of Pharmaceutical
Science and Research

A Global Platform for Open Access, Peer-Reviewed, and Indexed Research in the
Pharmaceutical and Medical Sciences



ISSN: 2583-6579


IF: 6.916



Submit Article

ABSTRACT

EVALUATION OF ANTI-ARTHRITIC, THROMBOLYTIC, AND ANTI-INFLAMMATORY ACTIVITIES OF GLYCOSMIS PENTAPHYLLA (RETZ.) DC

Md. Enamul Haque*, Dr. Md. Sohel Rana, and Dr. Md. Akbar Hossain

The present study evaluates the anti-arthritic, thrombolytic, and anti-inflammatory potential of various solvent fractions of Glycosmis pentaphylla (Retz.) DC. Phytochemical screening revealed the presence of flavonoids, alkaloids, phenolics, and tannins. The anti- arthritic activity was assessed by protein denaturation assay, thrombolytic activity was measured using a clot lysis assay, and anti-inflammatory activity was tested using egg albumin denaturation method. Among all fractions, the chloroform soluble fraction (CHSF) exhibited the most promising results with 82.56% inhibition of protein denaturation, 48.27% clot lysis, and 74.23% inhibition of albumin denaturation at 500 μg/mL. These findings support the ethnomedicinal use of G. pentaphylla and suggest its potential for development as a natural therapeutic agent.

[Full Text Article]

TRACK ARTICLE

NEWS

  • Impact Factor Increased

    We are pleased to inform you that our 2026 IMPACT FACTOR has increased from 5.111 to 6.916

    Email & SMS Alert

    We will provide you email alerts regarding New Issue Release, Publication of your Article, Invitaion for New Upcoming Issue, Manuscript releted Emails etc.

    June 2026 Issue Now Available

    June 2026 Issue is now available online for readers and contributors. Kindly check it on Click here

    Indexing

    This journal is indexed in world wide reputed commettee like: "DOI for all Articles" "Google Scholer" "SJIF Impact Factor:- 5.111" "Cosmos Impact Factor" "ISI Indexing" "International Impact Factor Services (IIFS)" "ResearchBib" etc.

    Upcoming Issue (2026)

    The journal invites researchers, academicians, and scholars to submit their original research articles, review papers, and case studies for the upcoming July 2026 Issue . All submissions will undergo a standard peer-review process.